NEUROPACE INC's ticker is NPCE and the CUSIP is 641288105. A total of 33 filers reported holding NEUROPACE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $583,488 | +259.8% | 59,968 | +66.0% | 0.00% | – |
| Q2 2023 | $162,164 | +7.6% | 36,117 | +11.2% | 0.00% | – |
| Q1 2023 | $150,666 | +192.7% | 32,471 | -6.0% | 0.00% | – |
| Q4 2022 | $51,474 | -45.8% | 34,547 | +35.8% | 0.00% | – |
| Q3 2022 | $95,000 | -12.8% | 25,446 | +15.2% | 0.00% | – |
| Q2 2022 | $109,000 | -96.0% | 22,086 | -93.4% | 0.00% | – |
| Q1 2022 | $2,752,000 | -19.7% | 335,202 | -1.4% | 0.00% | – |
| Q4 2021 | $3,428,000 | -35.2% | 340,087 | +1.8% | 0.00% | – |
| Q3 2021 | $5,294,000 | -33.5% | 333,974 | -0.2% | 0.00% | – |
| Q2 2021 | $7,959,000 | – | 334,495 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KCK LTD. | 5,621,111 | $27,824,000 | 39.09% |
| Revelation Capital Management, LLC | 248,127 | $1,228,000 | 17.38% |
| Soleus Capital Management, L.P. | 2,334,003 | $11,553,000 | 1.80% |
| Orbimed Advisors | 4,012,281 | $19,861,000 | 0.36% |
| Opaleye Management Inc. | 90,100 | $446,000 | 0.20% |
| Nantahala Capital Management | 478,438 | $2,368,000 | 0.12% |
| Bellevue Group AG | 507,930 | $2,514,000 | 0.04% |
| Ergoteles LLC | 34,800 | $172,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 26,148 | $129,000 | 0.00% |
| Point72 Asset Management, L.P. | 149,199 | $739,000 | 0.00% |